MicroRNA-34a regulates cardiac fibrosis after myocardial infarction by targeting Smad4

Bibliography

• Bornstein P, Sage EH. Matricellular proteins: extracellular modulators of cell function. Curr Opin Cell Biol 2002;14(5):608-16
   PubMed Web of Science ®Google Scholar
• Zamilpa R, Lindsey ML. Extracellular matrix turnover and signaling during cardiac remodeling following MI: causes and consequences. J Mol Cell Cardiol 2010;48(3):558-63
   Google Scholar
• Fihn SD, Vaughan-Sarrazin M, Lowy E, et al. Declining mortality following acute myocardial infarction in the Department of Veterans Affairs Health Care System. BMC Cardiovasc Disord 2009;9:44
   Google Scholar
• Dai Y, Khaidakov M, Wang X, et al. MicroRNAs involved in the regulation of postischemic cardiac fibrosis. Hypertension 2013;61(4):751-6
   PubMed Web of Science ®Google Scholar
• Latronico MV, Condorelli G. MicroRNAs and cardiac pathology. Nat Rev Cardiol 2009;6(6):419-29
   PubMed Web of Science ®Google Scholar
• Patrick DM, Montgomery RL, Qi X, et al. Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice. J Clin Invest 2010;120(11):3912-16
   PubMed Web of Science ®Google Scholar
• Lagendijk AK, Goumans MJ, Burkhard SB, et al. MicroRNA-23 restricts cardiac valve formation by inhibiting Has2 and extracellular hyaluronic acid production. Circ Res 2011;109(6):649-57
   Google Scholar
• Wang J, Huang W, Xu R, et al. MicroRNA-24 regulates cardiac fibrosis after myocardial infarction. J Cell Mol Med 2012;16(9):2150-60
   PubMed Web of Science ®Google Scholar
• van Rooij E, Sutherland LB, Thatcher JE, et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci USA 2008;105(35):13027-32
   PubMed Web of Science ®Google Scholar
• Zhou L, Wang L, Lu L, et al. Inhibition of miR-29 by TGF-beta-Smad3 signaling through dual mechanisms promotes transdifferentiation of mouse myoblasts into myofibroblasts. PLoS One 2012;7(3):e33766
   PubMed Web of Science ®Google Scholar
• Pan Z, Sun X, Shan H, et al. MicroRNA-101 inhibited postinfarct cardiac fibrosis and improved left ventricular compliance via the FBJ osteosarcoma oncogene/transforming growth factor-beta1 pathway. Circulation 2012;126(7):840-50
   PubMed Web of Science ®Google Scholar
• Katare R, Riu F, Mitchell K, et al. Transplantation of human pericyte progenitor cells improves the repair of infarcted heart through activation of an angiogenic program involving micro-RNA-132. Circ Res 2011;109(8):894-906
   PubMed Web of Science ®Google Scholar
• Winbanks CE, Wang B, Beyer C, et al. TGF-beta regulates miR-206 and miR-29 to control myogenic differentiation through regulation of HDAC4. J Biol Chem 2011;286(16):13805-14
   PubMed Web of Science ®Google Scholar
• He L, He X, Lim LP, et al. A microRNA component of the p53 tumour suppressor network. Nature 2007;447(7148):1130-4
   PubMed Web of Science ®Google Scholar
• Chang TC, Wentzel EA, Kent OA, et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 2007;26(5):745-52
   PubMed Web of Science ®Google Scholar
• Du R, Sun W, Xia L, et al. Hypoxia-induced down-regulation of microRNA-34a promotes EMT by targeting the Notch signaling pathway in tubular epithelial cells. PLoS One 2012;7(2):e30771
   PubMed Web of Science ®Google Scholar
• Xu Y, Liu L, Liu J, et al. A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular carcinoma. Int J Cancer 2010;128(2):412-17
   Google Scholar
• Li WQ, Chen C, Xu MD, et al. The rno-miR-34 family is upregulated and targets ACSL1 in dimethylnitrosamine-induced hepatic fibrosis in rats. FEBS J 2011;278(9):1522-32
   Web of Science ®Google Scholar
• Meng F, Glaser SS, Francis H, et al. Epigenetic regulation of miR-34a expression in alcoholic liver injury. Am J Pathol 2012;181(3):804-17
   PubMed Web of Science ®Google Scholar
• Boon RA, Iekushi K, Lechner S, et al. MicroRNA-34a regulates cardiac ageing and function. Nature 2013;495(7439):107-10
   PubMed Web of Science ®Google Scholar
• Bernardo BC, Gao XM, Winbanks CE, et al. Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function. Proc Natl Acad Sci USA 2012;109(43):17615-20
   PubMed Web of Science ®Google Scholar
• Bernardo BC, Gao XM, Tham YK, et al. Silencing of miR-34a attenuates cardiac dysfunction in a setting of moderate, but not severe, hypertrophic cardiomyopathy. PLoS One 2014;9(2):e90337
   PubMed Web of Science ®Google Scholar
• Dixon IM, Lee SL, Dhalla NS. Nitrendipine binding in congestive heart failure due to myocardial infarction. Circ Res 1990;66(3):782-8
   Google Scholar
• Ju H, Zhao S, Tappia PS, et al. Expression of Gq alpha and PLC-beta in scar and border tissue in heart failure due to myocardial infarction. Circulation 1998;97(9):892-9
   Google Scholar
• Krutzfeldt J, Rajewsky N, Braich R, et al. Silencing of microRNAs in vivo with ’antagomirs’. Nature 2005;438(7068):685-9
   PubMed Web of Science ®Google Scholar
• Kurrelmeyer KM, Michael LH, Baumgarten G, et al. Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction. Proc Natl Acad Sci USA 2000;97(10):5456-61
   PubMed Web of Science ®Google Scholar
• Alhaddad IA, Tkaczevski L, Siddiqui F, et al. Aspirin enhances the benefits of late reperfusion on infarct shape. A possible mechanism of the beneficial effects of aspirin on survival after acute myocardial infarction. Circulation 1995;91(11):2819-23
   Google Scholar
• Liang H, Zhang C, Ban T, et al. A novel reciprocal loop between microRNA-21 and TGFbetaRIII is involved in cardiac fibrosis. Int J Biochem Cell Biol 2012;44(12):2152-60
   Google Scholar
• Wang Y, Ren J, Gao Y, et al. MicroRNA-224 targets SMAD family member 4 to promote cell proliferation and negatively influence patient survival. PLoS One 2013;8(7):e68744
   Google Scholar
• Porter KE, Turner NA. Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol Ther 2009;123(2):255-78
   PubMed Web of Science ®Google Scholar
• Hao J, Ju H, Zhao S, et al. Elevation of expression of Smads 2, 3, and 4, decorin and TGF-beta in the chronic phase of myocardial infarct scar healing. J Mol Cell Cardiol 1999;31(3):667-78
   PubMed Web of Science ®Google Scholar
• Honeyman L, Bazett M, Tomko TG, et al. MicroRNA profiling implicates the insulin-like growth factor pathway in bleomycin-induced pulmonary fibrosis in mice. Fibrogenesis Tissue Repair 2013;6(1):16
   PubMedGoogle Scholar
• Xie T, Liang J, Guo R, et al. Comprehensive microRNA analysis in bleomycin-induced pulmonary fibrosis identifies multiple sites of molecular regulation. Physiol Genomics 2011;43(9):479-87
   Google Scholar
• Liu G, Friggeri A, Yang Y, et al. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J Exp Med 2010;207(8):1589-97
   PubMed Web of Science ®Google Scholar
• Eghbali M. Cellular origin and distribution of transforming growth factor-beta in the normal rat myocardium. Cell Tissue Res 1989;256(3):553-8
   Google Scholar
• Flanders KC, Winokur TS, Holder MG, et al. Hyperthermia induces expression of transforming growth factor-beta s in rat cardiac cells in vitro and in vivo. J Clin Invest 1993;92(1):404-10
   Google Scholar
• Lee AA, Dillmann WH, McCulloch AD, et al. Angiotensin II stimulates the autocrine production of transforming growth factor-beta 1 in adult rat cardiac fibroblasts. J Mol Cell Cardiol 1995;27(10):2347-57
   PubMedGoogle Scholar
• Takahashi N, Calderone A, Izzo NJ Jr, et al. Hypertrophic stimuli induce transforming growth factor-beta 1 expression in rat ventricular myocytes. J Clin Invest 1994;94(4):1470-6
   Google Scholar
• Engelmann GL, Grutkoski PS. Coordinate TGF-beta receptor gene expression during rat heart development. Cell Mol Biol Res 1994;40(2):93-104
   Google Scholar
• He Y, Huang C, Sun X, et al. MicroRNA-146a modulates TGF-beta1-induced hepatic stellate cell proliferation by targeting SMAD4. Cell Signal 2012;24(10):1923-30
   Web of Science ®Google Scholar
• Liu X, Hu H, Yin JQ. Therapeutic strategies against TGF-beta signaling pathway in hepatic fibrosis. Liver Int 2006;26(1):8-22
   Google Scholar
• Qin BY, Lam SS, Correia JJ, et al. Smad3 allostery links TGF-beta receptor kinase activation to transcriptional control. Genes Dev 2002;16(15):1950-63
   Google Scholar
• Dobaczewski M, Chen W, Frangogiannis NG. Transforming growth factor (TGF)-beta signaling in cardiac remodeling. J Mol Cell Cardiol 2011;51(4):600-6
   PubMed Web of Science ®Google Scholar
• Wang J, Xu N, Feng X, et al. Targeted disruption of Smad4 in cardiomyocytes results in cardiac hypertrophy and heart failure. Circ Res 2005;97(8):821-8
   Google Scholar